Work

Comparison of subcutaneous and intravenous infliximab in patients with inflammatory bowel disease showed no differences in immunogenicity or treatment persistence at 1 year

Year: 2024

Type: article

Study design: Observational Study

Source: Frontline Gastroenterology

DOI: 10.1136/flgastro-2024-102805

Authors: Sarah Hancox, Francesco Morda, Christopher J Black, Christian Philipp Selinger

Institutions: Leeds Teaching Hospitals NHS Trust, Policlinico San Matteo Fondazione

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403062840

FWCI: 1.223

Cites: 28

Cited by: 5

Related to: 10